Ly Phan, MD
Surgery · Columbia, MONPI 1356430870
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,500 of the $3,718 with a category attached, or 67.2%. Intuitive Surgical accounts for 67.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $2,699 and has fallen 96.9% since, to $84 in 2025.
Across 40 payments — averaging $92.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Davol Inc.$440
- Organogenesis Inc.$199
- Sanofi Pasteur Inc.$74
- 180 Medical, Inc.$69
- Baudax Bio Inc.$63
- plus $360 from 15 others
What the payments were for
- Food & beverage$1,21833%
- Education$2,50067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $2,513 |
| Davol Inc. | 4 | $440 |
| Organogenesis Inc. | 10 | $199 |
| Sanofi Pasteur Inc. | 3 | $74 |
| 180 Medical, Inc. | 3 | $69 |
| Baudax Bio Inc. | 2 | $63 |
| Daiichi Sankyo Inc. | 2 | $61 |
| Ferring Pharmaceuticals Inc. | 1 | $49 |
| Covidien LP | 1 | $29 |
| AstraZeneca | 1 | $29 |
| Bayer | 1 | $27 |
| Exact Sciences | 1 | $27 |
| Olympus America Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Merck | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Smith+Nephew | 1 | $11 |
| Medtronic | 1 | $11 |
| Endogastric Solutions, Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,500
- PHASIX$249
- Phasix Mesh$158
How this compares
$3,718 in reported general payments places this provider in the 65th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 52 | $412 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $325 |
| Sucralfate | 12 | $298 |
Paid to pharmacies, not to this prescriber.
Other surgery in Columbia
- John TannColumbia$216K
- Milot ThaqiColumbia$87K
- Andrew WheelerColumbia$66K
- Kevin BartowColumbia$54K
- Thomas XuColumbia$26K
- Norbert RichardsonColumbia$25K
- Forrest EricksenColumbia$21K
- Joshua LandreneauColumbia$17K
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.